SearcharxivSearch

arXiv subjects

J. Harter

Publications and source records attributed to J. Harter.

2 recordsLinked to original sources

Isotope Production in Fusion Systems

Fusion systems producing isotopes via neutron-driven transmutation can achieve economic viability well before reaching energy breakeven. Incorporating carefully selected feedstock materials in a blanket allows fusion systems to generate both electrical power and high-value isotopes, expanding the space of viable concepts, significantly enhancing the economic value of fusion energy, and supporting an accelerated path to adoption. We calculate the value of this co-generation and derive a new economic breakeven condition based on net present value. At lower plasma gain, $Q_{\mathrm{plas}}\lesssim 1$, high-value transmutation, such as medical radioisotopes, enables pure transmuter fusion systems operating at only watts to megawatts of fusion power: for example, a 3 megawatt system transmuting ${}^{102}\mathrm{Ru}\rightarrow{}^{99}\mathrm{Mo}$ could fulfill global ${}^{99}\mathrm{Mo}$ demand with $Q_{\mathrm{plas}} \ll 1$. At higher gain $Q_{\mathrm{plas}}\gtrsim 3$, it becomes viable to generate electricity in addition to isotopes. For example, co-production of electricity and gold, transmuted from mercury in a fusion blanket, can reduce the required plasma gain for economic viability from $Q_{\mathrm{plas}}\sim 10$-$100$ to $Q_{\mathrm{plas}}\sim 3$-$5$. We further highlight techniques to enhance transmutation with asymmetric neutron wall loading. Fusion neutron-driven transmutation therefore offers a revenue-positive pathway for deploying fusion energy at terawatt-scale, starting from smaller watt-to-megawatt-scale machines for radioisotope production and then scaling up to co-producing electricity and gold in larger fusion power plants.

physics.plasm-ph

Production of High-Specific-Activity Radioisotopes Using High-Energy Fusion Neutrons

We show that transmutation driven by high-energy neutrons from deuterium-tritium (D-T) fusion reactions can produce many important medical radioisotopes - including $^{32}$P, $^{60}$Co, $^{64}$Cu, $^{89}$Sr, $^{90}$Y, $^{89}$Zr, $^{99}$Mo/$^{99\mathrm{m}}$Tc, $^{103}$Pd, $^{111}$In, $^{117}$In/$^{117\mathrm{m}1}$Sn, $^{123}$I, $^{125}$I, $^{131}$I, $^{133}$Xe, $^{153}$Sm, $^{166}$Ho, $^{177}$Lu, $^{188}$Re, and $^{192}$Ir-and emerging isotopes such as $^{47}$Sc, $^{67}$Cu, $^{103}$Ru/$^{103\mathrm{m}}$Rh, $^{103}$Pd/$^{103\mathrm{m}}$Rh, $^{119}$Sb, $^{124}$I, $^{155}$Tb, $^{161}$Tb, $^{195\mathrm{m}1}$Ir/$^{195\mathrm{m}}$Pt, and $^{225}$Ac with high specific activity and in large quantities. These reactions involve stable, abundant feedstocks and non-fission transmutation channels that change the proton number, enabling chemical separation of the product. Fusion-based transmutation could provide a flexible and proliferation-resistant platform for supply of high-purity isotopes. A D-T neutron source operating at a few megawatts of fusion power could meet or exceed global demand for most major radioisotopes. Further research is required to develop tailored approaches for feedstock processing and product extraction.

nucl-ex